Rain Therapeutics Inc. (RAIN:NSQ) saw one of the biggest daily changes on Wall Street, down 16.4 percent throughout the day.
It fell $1.1, placing it 45th among the top 50 biggest swings in Wall Street during the time frame.
Shares in Rain Therapeutics Inc. finished on Sept. 28 at $5.61.
Rain Therapeutics Inc. employs 44 people and has reported -$71,420,000 USD in income.
Stock fluctuations are affected by several factors, from news about the company involved to global trade difficulties or successes.
Despite a tumultuous year with the COVID-19 pandemic, the US stock market overall remained strong in 2021.
Tony Despirito at investment firm BlackRock said “Overall, companies have beat analyst expectations on both earnings per share and revenue growth. But the latter has been particularly strong.”
Nothing in this article is to be assumed as financial advice.
Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.
| Company Name | Percentage Change | Current Trading Price |
|---|---|---|
| Acumen Pharmaceuticals Inc. | 103.8% | $9.58 |
| TraqIQ Inc. | 75% | $1.75 |
| BTRS Holdings Inc. | 60.8% | $9.28 |
| FingerMotion Inc. | 60.4% | $1.7 |
| Wells Fargo & Co. | 43.9% | $2.26 |
| Biogen Inc. | 39.9% | $276.61 |
| Positron Corp. | 39.2% | $1.03 |
| Virtual Interactive Technologies Corp. | 38.7% | $2.15 |
| X4 Pharmaceuticals Inc. | 38.1% | $1.45 |
| Green Planet Bio Engineering Co. Ltd. | 33.3% | $2 |
| Artemis Therapeutics Inc. | 32.4% | $2.9 |
| KLX Energy Services Holdings Inc. | 30.3% | $6.97 |
| 4 Less Group Inc. | 28.5% | $5.14 |
| Heartbeam Inc. | 27.9% | $3.44 |
| Neuronetics Inc. | 27.2% | $2.95 |
| Appgate Inc. | -25.9% | $4 |
| Fortium Holdings Corp. | -24.1% | $1.1 |
| Blue Apron Holdings Inc. | 24% | $6.21 |
| Manitex International Inc. | 23.9% | $5.7 |
| Quanterix Corp. | 23.8% | $10.41 |
| Odyssey Marine Exploration Inc. | 23% | $2.99 |
| Applied Molecular Transport Inc. | 22.2% | $1.1 |
| Sonendo Inc. | 20.7% | $1.46 |
| Can B Corp. | 20.5% | $2.65 |
| Ginkgo Bioworks Holdings Inc. | 20.1% | $3.47 |
| Brookfield DTLA Fund Office Trust Investor Inc. | 20.1% | $9.03 |
| Loyalty Ventures Inc. | -20% | $1.4 |
| Unico American Corp. | -19.9% | $1.21 |
| Zymergen Inc. | 19.5% | $3.06 |
| Aura Biosciences Inc. | 19.2% | $18.35 |
| Heliogen Inc. | 19.2% | $2.05 |
| PureTech Health PLC | 19% | $26.5 |
| Local Bounti Corp. | 18.2% | $2.86 |
| Cyclo Therapeutics Inc. | 18% | $2.03 |
| New Concept Energy Inc. | 17.7% | $1.33 |
| Denali Therapeutics Inc. | 17.7% | $32.12 |
| CVD Equipment Corp. | 17.6% | $5.35 |
| Immuneering Corp. | 17.5% | $12.45 |
| Rhythm Pharmaceuticals Inc. | 17.5% | $24.76 |
| Pear Therapeutics Inc. | 17.4% | $1.82 |
| Nuvalent Inc. | 17.3% | $19.7 |
| Priority Technology Holdings Inc. | 17.3% | $4.28 |
| Terns Pharmaceuticals Inc. | 17.1% | $5.76 |
| IN8BIO, Inc. | 16.7% | $2.1 |
| Rain Therapeutics Inc. | -16.4% | $5.61 |
| Owlet Inc. | 16.2% | $1.29 |
| Ocugen Inc. | 16% | $2.03 |
| Intrusion Inc. | 15.6% | $4.88 |
| Taysha Gene Therapies Inc. | 15.6% | $2.07 |
| View Inc. | 15.6% | $1.56 |
